Clinical Trials Browser

Phase 1/2 × Unknown × sacituzumab govitecan × Clear all

NCT06328387 2024-03-25

HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer

Phase 1/2 Unknown

Breast Neoplasms